SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Wellness Ltd (ZYDUSWELL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531335 NSE: ZYDUSWELL Consumer Food | Small Cap | Zydus Wellness Share Price

₹501.70 -0.75 (-0.15%)

As on 04-Jun'26 16:59

Zydus Wellness Ltd (ZYDUSWELL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531335 NSE: ZYDUSWELL Consumer Food | Small Cap | Zydus Wellness Share Price

₹501.70 -0.75 (-0.15%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹15,962 Cr.
Current Price
₹501.7
52-Week Low / High
₹358 / 552
TTM EPS
₹6.2
TTM Sales
₹3,940 Cr.
Book Value per Share
₹183.1
P/E Ratio
80.94
Higher than its 5-year historical median
Industry PE
55.5
Price to Book (P/B)
2.74
Higher than its 5-year historical median
Price to Sales (P/S)
4.05
Lower than its 5-year historical median
EV/EBITDA
36.89
Higher than its 5-year historical median
Dividend Yield
0.36%
Profitability Efficiency
Return on Equity (ROE)
6.29%
Underperforms industry median
Return on Capital Employed (ROCE)
6.43%
Underperforms industry median
Return on Assets (ROA)
5.65%
Operating Profit Margin
14%
Net Profit Margin
12.81%
Gross Profit Margin
13%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
16.37%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
22.98%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
29.97%
Asset Quality
Promoter Holding
69.64%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹5,762 Cr.
Equity
₹63.6 Cr.
Face Value
₹2
All Time Low / High
₹0.41 / 552.40

Zydus Wellness stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Zydus Wellness Ltd a good quality company?
Zydus Wellness Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Zydus Wellness Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Zydus Wellness Ltd vs industry peers?
Zydus Wellness Ltd revenue CAGR is 8.92%, compared to the industry median CAGR of 7.03%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Zydus Wellness Ltd?
Promoters hold 69.64% of the Zydus Wellness Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Zydus Wellness Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 12.4% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Zydus Wellness Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 26.4%23.5%23.3%7.1%5.3%3.9%6.4%5.8%5.1%6.4%-
Value Creation
Index
0.90.70.7-0.5-0.6-0.7-0.5-0.6-0.6-0.5-

Growth Parameters

Sales 3974315138431,7671,8672,0092,2552,3282,7093,940
Sales YoY Gr.-8.5%19.1%64.4%109.6%5.7%7.6%12.2%3.2%16.4%-
Adj EPS 5.35.56.75.75.96.69.7108.710.66.2
YoY Gr.-5.1%21.5%-15.8%3.4%13.3%46.5%2.3%-13.1%22.2%-
BVPS (₹) 24.528.535.4117.5120143.6152.3161.1168.5178.4183.1
Adj Net
Profit
103108132164169211310317275336197
Cash Flow from Ops. 89.97769.114925928723791.7246380-
Debt/CF from Ops. 00.30.410.55.91.91.63.21.30.5-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 23.8%8.9%10.5%16.4%
Adj EPS 8%12.5%2.8%22.2%
BVPS24.7%8.2%5.4%5.9%
Share Price 12.5% 3.7% 19.4% 32.8%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
23.320.921.184.95.36.66.45.36.13.4
Op. Profit
Mgn %
2323.124.421.918.218.517.11513.21412.8
Net Profit
Mgn %
26.525.726.219.79.611.315.41411.812.45
Debt to
Equity
0000.50.40.10.10.10.100.5
Working Cap
Days
73555014211011011411812812262
Cash Conv.
Cycle
-50-51-45-67-45-34-924393829

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3974315138431,7671,8672,0092,2552,3282,709
Operating Expenses + 3053323876581,4461,5221,6671,9182,0202,330
Manufacturing Costs5456661081031027898104109
Material Costs81921132167798459801,1461,1381,278
Employee Cost 39455482152159159162193237
Other Costs 131138154252411416450512584706
Operating Profit 9199125185321344342337308379
Operating Profit Margin (%) 23.0%23.0%24.4%21.9%18.2%18.4%17.0%15.0%13.2%14.0%
Other Income + 323335391191351414
Exceptional Items 000-10-44-1320-10-146
Interest 012301408426162412
Depreciation 77913262524252428
Profit Before Tax 117124150171121112306291260359
Tax 121313-1-20-7-3-20-712
Profit After Tax 105111137171142119309310267347
PAT Margin (%) 26.5%25.8%26.6%20.3%8.0%6.4%15.4%13.8%11.5%12.8%
Adjusted EPS (₹)5.35.66.95.94.93.79.79.88.410.9
Dividend Payout Ratio (%)24.60%23.30%23.30%17.10%20.30%26.80%10.30%10.20%11.90%11%

Valuation of Zydus Wellness - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 4795576913,3863,4614,5684,8445,1235,3585,672
Share Capital 39393958586464646464
Reserves 4395186523,3293,4034,5044,7805,0595,2945,608
Debt +025251,5691,519550132230324185
Long Term Debt0001,5001,50031363000
Short Term Debt02525691923769230324185
Minority Interest911130000000
Trade Payables636779392504439364313363429
Others Liabilities 17-33-538-15-1631118-5212
Total Liabilities 5686267555,3565,4695,5405,6515,6845,9926,297

Fixed Assets

Net Fixed Assets +821031044,5674,6744,6674,7104,7324,7085,125
Gross Block1171441544,7124,8444,8584,9194,9614,9345,389
Accumulated Depreciation354251144170190209228226264
CWIP 000104412131015
Investments 943014846110027707836
Inventories243235233292365362458468518
Trade Receivables3499611894142208283367
Cash Equivalents 305440414164822531703824074
Others Assets 601746238188157228165207162
Total Assets 5686267555,3565,4695,5405,6515,6845,9926,297

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 90776914925928723792246380
PBT 117124150171121112306291260359
Adjustment -25-23-21-816324041423345
Changes in Working Capital 12-15-4849-23-66-106-240-44-27
Tax Paid -14-9-12-63-20-4-1-33
Cash Flow From Investing Activity + -28-72-59-4,162-17-10-86-85-178-224
Capex -4-31-8-17-25-17-75-44-26-65
Net Investments -55-73-83460-30-21-41-5-314
Others 313132-4,60411791-147156
Cash Flow From Financing Activity + -58-6-24,052-260-216-234-139-26-186
Net Proceeds from Shares 00-02,57509870000
Net Proceeds from Borrowing 0001,5000-1,320-188-250-630
Interest Paid -0-10-30-140-101-32-16-24-14
Dividend Paid -48-25-2-31-58-0-32-32-32-32
Others -1020038-622181815992-141
Net Cash Flow 4-1839-1860-83-13243-30

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)23.7921.4921.878.44.142.966.566.235.096.29
ROCE (%)26.4423.4823.337.085.263.886.415.775.126.43
Asset Turnover Ratio0.790.770.750.280.360.370.380.430.430.48
PAT to CFO Conversion(x)0.860.690.50.871.822.410.770.30.921.1
Working Capital Days
Receivable Days1.802.704.5022.7020.3019.3020.1026.403640.40
Inventory Days21.4022.1023.4058.1049.7059.6061.6061.8067.8061.20
Payable Days256.10257.40234.50397.10210.20203.70149.50107.90108.40113.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zydus Wellness Ltd FAQs

The current trading price of Zydus Wellness on 04-Jun-2026 16:59 is ₹501.7.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Zydus Wellness stood at ₹15,962.1 Cr

The latest P/E ratio of Zydus Wellness as of 03-Jun-2026 is 424.5.

The latest P/B ratio of Zydus Wellness as of 03-Jun-2026 is 3.96.

The 52-week high of Zydus Wellness is ₹552.4 and the 52-week low is ₹357.6.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zydus Wellness is ₹528 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Zydus Wellness Ltd is a average quality company.

The key valuation ratios of Zydus Wellness Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Zydus Wellness Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Zydus Wellness Ltd

Zydus Wellness Ltd. is established in 1988. The company is a leading consumer wellness company with an Indian heritage and a global footprint. It believes, a healthy lifestyle is not just about being active but also about feeling good from within. So, it approaches health and wellness in a holistic manner. It nourishes, nurture and energize millions of lives by offering a variety of innovative, industry-leading products. With several years of operational excellence, it has seven leading brands in its portfolio, namely Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Sugarlite and Nutralite.

Headquartered in Ahmedabad and Mumbai, it has many manufacturing facilities across several locations - Aligarh, Sitarganj. Ahmedabad and Sikkim. It also has 8 co-packing facilities in India, Oman and Newzealand. Its core pillars -manufacturing integrity, supply chain efficiency, and product innovation, form the basis of the legacy it has built over the last few decades. Currently the Zydus Wellness business spans over several countries and many continents. It combines the best of healthcare, nutrition and cosmeceutical products to provide quality wellness products. It helps people pursue integrated well-being through its widening range of products.

Business area of the company

The company is an integrated consumer company. The Company is engaged in the development, production, marketing and distribution of health and wellness products.

Product of the Company

The Company has a wide range of health and wellness products. The Company’s product portfolio includes popular brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite.

Awards

2017-18

  • Its Sikkim plant received the Gold Award at the National Award for Manufacturing Competitiveness (NAMC), conducted by International Research Institute of Manufacturing.
  • Its flagship brand Sugar Free won the ‘Best Integration of Brand and Movie’ award at the Prime Time Awards 2017 for its association with the Bollywood film, ‘Chef’.
  • National Gold Award for Manufacturing Competitiveness.

2018-19

  • The Sikkim plant was presented with the Gold award by the International Research Institute of Manufacturing. 
  • The Ahmedabad plant (Nutralite) was presented the Silver award by the International Research Institute of Manufacturing at the National Award for Manufacturing Competitiveness 2018. 
  • The Sikkim plant was presented the Silver award at the India Manufacturing Excellence Award held by Frost and Sullivan. 
  • The Company was presented the Best SLIM Lead Award for manufacturing facilities in an exercise organised by the Zydus group. 
  • Won the India Packaging Award for Sugar Free Green Veda pack for Excellence in Packaging Design.
  • Won three Inflection Awards for the Best Procurement Team of the Year, 2018. 
  • Sugar Free won the Gold Award at Abby Awards (Publishers) for the Company’s West Bengal initiative with ABP.

2019-20

  • Most Trusted Brands 2020

Milestones

  • 1988: Launched Sugar Free with Aspartame.
  • 1991: Launched the Everyuth skincare range.
  • 2005: Introduced Sugar Free Natura with Sucralose.
  • 2006: Acquired Carnation NutraAnalogue Foods Ltd.
  • 2009: Restructured the consumer business of Cadila Healthcare Ltd., renamed Zydus Wellness Ltd.
  • 2011: Inaugurated the manufacturing plant in Sikkim.
  • 2017: Commissioned the new production facility in Sikkim.
  • 2017: Launched Sugar Free Green with Stevia.
  • 2018: Introduced Nutralite Mayonnaise in three appealing flavours: vegetable, cheese garlic and achari.
  • 2019: Acquired Heinz India Pvt. Ltd.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×